World’s first synthetic cell with a complete life cycle could revolutionize biological engineering

Researchers at the University of Minnesota Twin Cities have developed SpudCell, the world’s first synthetic cell constructed entirely from non-living chemical components that exhibits a complete life cycle. This breakthrough demonstrates that fundamental biological functions such as growth and replication can be engineered without natural precursors, utilizing a modular genome significantly smaller than previously theorized minimums. The development marks a pivotal shift for the synthetic biology sector, offering a programmable chassis for advanced molecular medicine and sustainable industrial manufacturing.

Led by Associate Professors Kate Adamala and Aaron Engelhart, the SpudCell project successfully replicated the complete set of behaviors of a living cell using only chemistry. The synthetic organism’s genome is comprised of 90 kilobase pairs (kbp), which is notably smaller than the 113 kbp previously speculated by biologists as the minimum requirement for life. This genome is uniquely structured across seven separate DNA plasmids, a modular design that allows researchers to program specific cellular functions independently and paves the way for increasingly complex behaviors in future iterations.

To transition this discovery from a laboratory success to a scalable engineering pipeline, Adamala and external partners are launching Biotic, a public-benefit research and engineering institution. Biotic aims to establish an open, shared technical infrastructure and standardized protocols for synthetic cell engineering, addressing the current lack of modularity and common standards between different laboratories. Adamala emphasized that building this foundation in the open is essential to prevent private infrastructure from hindering the progress of the discipline, noting that current knowledge transfer often requires in-person demonstrations that are not scalable.

The implications for the synthetic biology market are extensive, particularly in replacing traditional industrial chemistry with biological transformations. SpudCell provides a truly engineerable platform capable of producing precise therapeutic molecules, including drugs that incorporate amino acids not found in natural evolution. Furthermore, the technology enables the growth of materials and the execution of manufacturing processes at biological temperatures, significantly reducing the energy costs and harsh chemical requirements associated with current industrial standards. This platform represents a shift from co-opting natural cells to building bespoke biological machines from the ground up.